{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:52:08Z","timestamp":1790776328888,"version":"4.1.0"},"update-to":[{"DOI":"10.1016\/j.biopsych.2019.04.026","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000}}],"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AG049477"],"award-info":[{"award-number":["R21AG049477"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AT007411"],"award-info":[{"award-number":["R01AT007411"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG050253"],"award-info":[{"award-number":["R01AG050253"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.biopsych.2019.04.026","type":"journal-article","created":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T11:51:39Z","timestamp":1556797899000},"page":"208-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["RETRACTION OF: A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces \u03b2-Amyloid-Associated Pathology, and Improves Cognition"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3599-6859","authenticated-orcid":false,"given":"Darrell","family":"Sawmiller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9496-3681","authenticated-orcid":false,"given":"Ahsan","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anran","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Giunta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Sanberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Mattson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2019.04.026_bib1","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer\u2019s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.biopsych.2019.04.026_bib2","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2019.04.026_bib3","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer\u2019s disease: Genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.biopsych.2019.04.026_bib4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: Progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2019.04.026_bib5","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1021\/jm00021a001","article-title":"Therapeutic approaches related to amyloid-\u03b2 peptide and Alzheimer\u2019s disease","volume":"38","author":"Schenk","year":"1995","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.biopsych.2019.04.026_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1749-6632.1996.tb34401.x","article-title":"The role of APP processing and trafficking pathways in the formation of amyloid \u03b2-protein","volume":"777","author":"Selkoe","year":"1996","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.biopsych.2019.04.026_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng0195-21","article-title":"The Alzheimer\u2019s A\u03b2 peptide induces neurodegeneration and apoptotic cell death in transgenic mice","volume":"9","author":"LaFerla","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2019.04.026_bib8","doi-asserted-by":"crossref","first-page":"7951","DOI":"10.1073\/pnas.90.17.7951","article-title":"Apoptosis is induced by \u03b2-amyloid in cultured central nervous system neurons","volume":"90","author":"Loo","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2019.04.026_bib9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1084\/jem.188.3.431","article-title":"Complement-dependent proinflammatory properties of the Alzheimer\u2019s disease \u03b2-peptide","volume":"188","author":"Bradt","year":"1998","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.biopsych.2019.04.026_bib10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0006-8993(98)00780-X","article-title":"Alzheimer\u2019s \u03b2-amyloid peptides induce inflammatory cascade in human vascular cells: The roles of cytokines and CD40","volume":"807","author":"Suo","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2019.04.026_bib11","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1073\/pnas.91.8.3270","article-title":"A\u00a0model for \u03b2-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer disease","volume":"91","author":"Hensley","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2019.04.026_bib12","doi-asserted-by":"crossref","first-page":"15168","DOI":"10.1021\/ja054041c","article-title":"Formation and stabilization model of the 42-mer A\u03b2 radical: Implications for the long-lasting oxidative stress in Alzheimer\u2019s disease","volume":"127","author":"Murakami","year":"2005","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.biopsych.2019.04.026_bib13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3233\/JAD-2006-9S328","article-title":"Progress from Alzheimer\u2019s tangles to pathological tau points towards more effective therapies now","volume":"9","author":"Lee","year":"2006","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2019.04.026_bib14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/ana.410190502","article-title":"Epidemiology of clinically diagnosed Alzheimer\u2019s disease","volume":"19","author":"Rocca","year":"1986","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2019.04.026_bib15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/sj.ijo.802225","article-title":"Lower cognitive function in the presence of obesity and hypertension: The Framingham Heart Study","volume":"27","author":"Elias","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.biopsych.2019.04.026_bib16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1474-4422(10)70277-5","article-title":"Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer\u2019s disease","volume":"10","author":"Kapogiannis","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.biopsych.2019.04.026_bib17","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1038\/475S20a","article-title":"Genetics: Finding risk factors","volume":"475","author":"Eisenstein","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.04.026_bib18","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"issue":"suppl","key":"10.1016\/j.biopsych.2019.04.026_bib19","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1194\/jlr.R800069-JLR200","article-title":"Apolipoprotein E: Structure determines function, from atherosclerosis to Alzheimer\u2019s disease to AIDS","volume":"50","author":"Mahley","year":"2009","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.biopsych.2019.04.026_bib20","doi-asserted-by":"crossref","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","article-title":"Human apoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance","volume":"3","author":"Castellano","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.biopsych.2019.04.026_bib21","doi-asserted-by":"crossref","first-page":"18700","DOI":"10.1073\/pnas.0508693102","article-title":"Apolipoprotein (apo) E4 enhances amyloid \u03b2 peptide production in cultured neuronal cells: ApoE structure as a potential therapeutic target","volume":"102","author":"Ye","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2019.04.026_bib22","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1073\/pnas.1434398100","article-title":"Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer\u2019s disease-like neurodegeneration and behavioral deficits in transgenic mice","volume":"100","author":"Harris","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2019.04.026_bib23","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1523\/JNEUROSCI.4315-03.2004","article-title":"Neuron-specific apolipoprotein E4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice","volume":"24","author":"Brecht","year":"2004","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2019.04.026_bib24","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","article-title":"Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector","volume":"24","author":"Wang","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.biopsych.2019.04.026_bib25","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2019.04.026_bib26","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1007\/s12035-018-1237-z","article-title":"APOE and Alzheimer\u2019s disease: Evidence mounts that targeting APOE4 may combat Alzheimer\u2019s pathogenesis","volume":"56","author":"Uddin","year":"2019","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.biopsych.2019.04.026_bib27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.biopsych.2017.03.003","article-title":"Apolipoprotein E, receptors, and modulation of Alzheimer\u2019s disease","volume":"83","author":"Zhao","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2019.04.026_bib28","doi-asserted-by":"crossref","first-page":"13892","DOI":"10.1016\/S0021-9258(19)57838-3","article-title":"Physical interaction of ApoE with amyloid precursor protein independent of the amyloid A\u03b2 region in\u00a0vitro","volume":"273","author":"Hass","year":"1998","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biopsych.2019.04.026_bib29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cell.2016.12.044","article-title":"ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and A\u03b2 secretion","volume":"168","author":"Huang","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.biopsych.2019.04.026_bib30","doi-asserted-by":"crossref","first-page":"8807","DOI":"10.1523\/JNEUROSCI.1521-05.2005","article-title":"Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice","volume":"25","author":"Rezai-Zadeh","year":"2005","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2019.04.026_bib31","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ncomms1781","article-title":"Soluble amyloid precursor protein-\u03b1 modulates \u03b2-secretase activity and amyloid-\u03b2 generation","volume":"3","author":"Obregon","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.biopsych.2019.04.026_bib32","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1523\/JNEUROSCI.3268-10.2011","article-title":"CD45 deficiency drives amyloid-\u03b2 peptide oligomers and neuronal loss in Alzheimer\u2019s disease mice","volume":"31","author":"Zhu","year":"2011","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2019.04.026_bib33","doi-asserted-by":"crossref","first-page":"e1374","DOI":"10.1038\/cddis.2014.336","article-title":"Specific antibody binding to the APP672-699 region shifts APP processing from \u03b1- to \u03b2-cleavage","volume":"5","author":"Li","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.biopsych.2019.04.026_bib34","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1016\/j.heliyon.2017.e00279","article-title":"Beneficial effects of a pyrroloquinolinequinone-containing dietary formulation on motor deficiency, cognitive decline and mitochondrial dysfunction in a mouse model of Alzheimer\u2019s disease","volume":"3","author":"Sawmiller","year":"2017","journal-title":"Heliyon"},{"key":"10.1016\/j.biopsych.2019.04.026_bib35","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jneuroim.2016.08.018","article-title":"Diosmin reduces cerebral A\u03b2 levels, tau hyperphosphorylation, neuroinflammation, and cognitive impairment in the 3xTg-AD mice","volume":"299","author":"Sawmiller","year":"2016","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.biopsych.2019.04.026_bib36","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0092-8674(93)90312-E","article-title":"Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide","volume":"75","author":"Haass","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.biopsych.2019.04.026_bib37","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/jnr.23823","article-title":"Restoring soluble amyloid precursor protein \u03b1 functions as a potential treatment for Alzheimer\u2019s disease","volume":"95","author":"Habib","year":"2017","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.biopsych.2019.04.026_bib38","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1007\/s12035-017-0806-x","article-title":"Trafficking in Alzheimer\u2019s disease: Modulation of APP transport and processing by the transmembrane proteins LRP1, SorLA, SorCS1c, sortilin, and calsyntenin","volume":"55","author":"Eggert","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.biopsych.2019.04.026_bib39","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/alzrt211","article-title":"The role of APP and BACE1 trafficking in APP processing and amyloid-\u03b2 generation","volume":"5","author":"Zhang","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.biopsych.2019.04.026_bib40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pneurobio.2017.05.005","article-title":"Small things matter: Implications of APP intracellular domain AICD nuclear signaling in the progression and pathogenesis of Alzheimer\u2019s disease","volume":"156","author":"Bukhari","year":"2017","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.biopsych.2019.04.026_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fnmol.2017.00003","article-title":"Role of APP interactions with heterotrimeric G proteins: Physiological functions and pathological consequences","volume":"10","author":"Copenhaver","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.biopsych.2019.04.026_bib42","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/jnc.12675","article-title":"Insights into the physiological function of the \u03b2-amyloid precursor protein: Beyond Alzheimer\u2019s disease","volume":"129","author":"Dawkins","year":"2014","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.biopsych.2019.04.026_bib43","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.tips.2016.01.005","article-title":"APP Receptor? To be or not to be","volume":"37","author":"Deyts","year":"2016","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.biopsych.2019.04.026_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jnc.14122","article-title":"The physiological role of the amyloid precursor protein as an adhesion molecule in the developing nervous system","volume":"143","author":"Sosa","year":"2017","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.biopsych.2019.04.026_bib45","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrn2620","article-title":"Apolipoprotein E and its receptors in Alzheimer\u2019s disease: Pathways, pathogenesis and therapy","volume":"10","author":"Bu","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2019.04.026_bib46","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(94)91804-X","article-title":"Protective effect of apoE \u03b52 in Alzheimer\u2019s disease","volume":"344","author":"Benjamin","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.biopsych.2019.04.026_bib47","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.neubiorev.2013.10.010","article-title":"The forgotten APOE allele: A review of the evidence and suggested mechanisms for the protective effect of APOE \u03b52","volume":"37","author":"Suri","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2019.04.026_bib48","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/bj3480359","article-title":"Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer\u2019s amyloid \u03b2 peptides","volume":"348","author":"Tokuda","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/j.biopsych.2019.04.026_bib49","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jnr.490320212","article-title":"Secretion of apolipoprotein E by an astrocytoma cell line","volume":"32","author":"Krul","year":"1992","journal-title":"J\u00a0Neurosci Res"}],"updated-by":[{"DOI":"10.1016\/j.biopsych.2025.10.019","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000}},{"DOI":"10.1016\/j.biopsych.2019.04.026","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000}},{"DOI":"10.1016\/j.biopsych.2025.10.019","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000}}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000632231931323X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000632231931323X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T12:22:38Z","timestamp":1768393358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000632231931323X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S000632231931323X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2019.04.026","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTION OF: A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces \u03b2-Amyloid-Associated Pathology, and Improves Cognition","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2019.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}